Sunday, 20 September 2026European Markets

Bank Of Ireland Stock Plummets 16% In Recent Sessions - What's Behind The Decline?

Loading stream...

(VIANEWS) - Dublin, Ireland - Shares of BANK OF IR NC PREF (ISEQ All Share: DD7E.IR) have experienced an alarming 16.01% drop over the last five trading sessions, losing 16.01% in value from opening at EUR24.05.20 at 15:27 EST to closing at EUR20.20 by 15:27 EST Tuesday 15th August; continuing its downward spiral and suffering five straight sessions of losses. The Irish Stock Exchange All Share Index, which tracks all companies listed on its main market, has also seen its value fall by 0.43% to EUR8,837.27 as of 15:27 EST today - following two consecutive days of losses for this index. Investors should closely track the performance of these stocks and the market as recent declines could signal a shift in sentiment.

More news about BANK OF IR NC PREF (DD7E.IR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com